What is the recommended management approach for a patient with diabetes and a history of foot complications during diabetic foot rounds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Foot Rounds: Recommended Management Approach

All patients with diabetes and a history of foot complications require structured multidisciplinary care with examination frequency every 1-3 months, risk-stratified assessment, patient education on daily foot inspection and appropriate footwear, and immediate referral protocols for new ulcers or infections. 1

Risk Stratification and Examination Frequency

Patients with a history of foot ulceration or lower-extremity amputation are classified as IWGDF Category 3 (highest risk) and require examination every 1-3 months. 1, 2

Comprehensive Examination Components

Each examination must systematically assess:

History Assessment:

  • Previous ulcer/amputation details 1
  • End stage renal disease status 1
  • Previous foot education received 1
  • Social isolation and healthcare access barriers 1
  • Barefoot walking behaviors 1
  • Claudication or rest pain symptoms 1

Vascular Assessment:

  • Palpation of dorsalis pedis and posterior tibial pulses 1
  • Ankle-brachial index if symptoms or signs of peripheral arterial disease present 1, 3
  • History of claudication, rest pain, or decreased walking speed 3

Neurological Assessment:

  • 10-g Semmes-Weinstein monofilament testing (primary test for loss of protective sensation) 1, 2
  • 128-Hz tuning fork for vibration perception 1, 2
  • Pin prick discrimination on dorsum of foot 1
  • Achilles tendon reflexes 1

Dermatological Assessment:

  • Callus formation (indicates increased plantar pressure) 1
  • Skin color, temperature differences, and edema 1
  • Pre-ulcerative signs 1

Musculoskeletal Assessment:

  • Foot deformities including claw toes, hammer toes, bunions, prominent metatarsal heads 1
  • Charcot foot changes 2
  • Limited joint mobility 1

Footwear Assessment:

  • Inspect both inside and outside of shoes worn at home and outside 1

Patient Education Protocol

Education must be delivered in multiple structured sessions over time using mixed methods, with verification that the patient and family understand and can demonstrate skills. 1

Critical Daily Self-Care Instructions

Daily foot inspection requirements:

  • Inspect all foot surfaces including between toes daily 1
  • Use unbreakable mirror if loss of protective sensation present 1, 3
  • Notify healthcare provider immediately if increased temperature, blisters, cuts, scratches, or ulcers develop 1

Footwear behaviors:

  • Never walk barefoot, in socks only, or in thin-soled slippers indoors or outdoors 1, 2
  • Inspect inside all shoes before wearing 1
  • Wear prescribed therapeutic footwear consistently 2

Hygiene practices:

  • Wash feet daily with water temperature below 37°C 1
  • Dry carefully, especially between toes 1
  • Apply emollients to dry skin but not between toes 1
  • Never use heaters or hot-water bottles on feet 1

Nail care:

  • Cut toenails straight across 1
  • Never use chemical agents or plasters for corns/calluses 1

Therapeutic Footwear Prescription

For Category 3 patients (history of ulcer/amputation), prescribe therapeutic footwear with demonstrated 30% plantar pressure relief compared to standard therapeutic footwear. 2

  • Patients with neuropathy or increased plantar pressures require well-fitted walking shoes or athletic shoes that cushion feet and redistribute pressure 1, 3
  • Patients with bony deformities need extra wide or deep shoes 1, 3
  • Patients with severe deformities including Charcot foot require custom-molded shoes if commercial therapeutic footwear cannot accommodate 3

Management of Active Ulcers

When new ulcers develop, immediate assessment must include probe-to-bone test and plain radiographs, followed by MRI if soft tissue abscess or osteomyelitis suspected. 4

First-line therapies for active diabetic foot ulcers:

  • Surgical debridement 4, 5
  • Off-loading with total contact cast or irremovable fixed ankle walking boot for plantar ulcers 4
  • Treatment of lower extremity ischemia 4, 5
  • Treatment of foot infection 4, 5

For ulcers failing to improve (>50% wound area reduction) after minimum 4 weeks of standard wound therapy, add adjunctive wound therapy options. 4

Patients with diabetic foot ulcer and peripheral arterial disease require revascularization by either surgical bypass or endovascular therapy. 4

Multidisciplinary Team Referral

Multidisciplinary care involving podiatrists, infectious disease specialists, and vascular surgeons in collaboration with primary care is associated with lower major amputation rates (3.2% vs 4.4%; odds ratio 0.40). 5

Immediate referral to multidisciplinary foot team indicated for:

  • New ulceration 1
  • Signs of infection (fever, erythema >1.5 cm surrounding ulcer, purulent discharge) 1
  • Suspected osteomyelitis 1
  • Critical limb ischemia 3

Systemic Risk Factor Management

Optimize glycemic control targeting HbA1c <7% to reduce microvascular complications and improve limb-related outcomes including lower amputation rates. 3

Smoking cessation interventions combining behavioral therapy and pharmacotherapy (nicotine replacement, bupropion, or varenicline) must be offered at every clinical encounter. 3

For patients with peripheral arterial disease:

  • Aspirin 75-325 mg daily as first-line antiplatelet therapy 3
  • ACE inhibitors for symptomatic PAD to reduce cardiovascular events by approximately 25% 3

Common Pitfalls to Avoid

  • Do not rely solely on pedal pulse palpation; obtain ankle-brachial index when clinical suspicion of PAD exists 3
  • Do not assume absence of symptoms excludes foot disorders; patients may have asymptomatic neuropathy, PAD, or even ulcers 1
  • Beta-blockers do not worsen claudication and are safe in PAD patients 3
  • Patients with visual difficulties, physical constraints, or cognitive problems require family member assistance with foot care 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetic Foot Care Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Lower Arterial Disease in Diabetic Foot Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.